Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Comment by jtcommonon Dec 29, 2015 9:02am
127 Views
Post# 24416131

RE:RE:RE:VRX CEO hit with "severe" pneumonia.

RE:RE:RE:VRX CEO hit with "severe" pneumonia.Hope that Mr. Pearson will have a speedy recovery.

The appointment of a trio to fill in for Mr. Pearson highlights at least another concern for me regarding the company -- Valeant does not have a succession plan.

Of courses, this is bad news among many headwinds Valeant is facing.  But if the SP tests Novemeber low in the near future, the stock might just be worth a look.

-JT
<< Previous
Bullboard Posts
Next >>